CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Elite Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Elite Pharmaceuticals Inc
165 Ludlow Ave
Phone: (201) 750-2646p:201 750-2646 NORTHVALE, NJ  07647-2305  United States Ticker: ELTPELTP

Business Summary
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets generic controlled-release and abuse deterrent pharmaceutical products. Its segments include Abbreviated New Drug Applications (ANDA's) for generic products and New Drug Applications (NDA's) for branded products. The Company owns approximately six different approved ANDA's. The Company's product, SequestOx, is an immediate-release Oxycodone Hydrochloride containing sequestered Naltrexone, which incorporates five milligram, 10 milligram, 15 milligram, 20 milligram and 30 milligram doses of oxycodone into capsules. SequestOx is used for the management of moderate to severe pain where the use of an opioid analgesic is appropriate.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20193/31/2019YesYes-Yes-

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer NasratHakim 53 1/13/2016 8/1/2013
Chairman of the Board Jerry I.Treppel 60 8/2/2013 10/28/2008
Chief Financial Officer, Treasurer, Secretary Carter J.Ward 51 7/1/2009 7/1/2009
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Elite Laboratories, Inc.
ELTP
Trimipramine ANDA

General Information
Number of Employees: 35 (As of 3/31/2019)
Outstanding Shares: 832,942,060 (As of 10/7/2019)
Shareholders: 122
Stock Exchange: OTC
Federal Tax Id: 223542636
Fax Number: (201) 750-2755
Email Address: elitelabs@aol.com


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 15, 2019